Point-of-Care Quick ReferenceAAP Textbook of Pediatric CareBright FuturesBright Futures Pocket GuidePediatric Drug LookupAntimicrobial Therapy GuideVisual LibraryPediatric Care Updates
Interactive Periodicity ScheduleSigns & Symptoms SearchAlgorithmsPatient HandoutsForms & ToolsClinical Calculators
Contact UseAlerts Sign-upSite TourSite HelpFAQ
Point-of-Care Quick Reference

Atopic Dermatitis

Definition

  • Atopic dermatitis (AD) is a multifactorial dermatologic condition involving chronic inflammation of the skin.
  • Sometimes referred to as eczema, a general term to describe skin that is erythematous, scaling, vesicular, and crusting.
  • May be the initial condition signaling the progression to further allergic disease, known as the atopic march
  • Associated immunoglobulin E (IgE)-mediated diseases

Epidemiology

  • Prevalence
    • >10% of infants and young children may be affected.
    • ~5% of adolescents are affected.
    • In 2007, 18 million Americans had a self-reported diagnosis, with more than one-third having the diagnosis confirmed by a physician.
  • Age
    • Predominantly disease of infancy and childhood
    • Onset occurs in first year of life in the majority of affected individuals.
  • Sex
    • Both sexes are affected equally.

Etiology

  • The exact cause is unknown, but genetic and environmental factors play a role.
  • Involves:
    • Dysfunction of the epidermal barrier and
    • Dysfunction of the immune system
      • Abnormal IgE-mediated (type I) reaction
      • Abnormal cell-mediated (type IV) reaction
  • The hygiene hypothesis states that decreased exposure to microbes stunts immunologic maturation of Th1 cells.
  • Other cells implicated in the development of AD
    • Macrophages
    • IgE-bearing Langerhans cells
    • Eosinophils
    • Mast cells
    • Resulting inflammatory reactions lead to disruption of the epidermis.
  • Potential antigenic triggers
    • Airborne allergens (dust mites, cat and dog dander, molds, pollen)
    • Foods (especially milk, eggs, peanuts)
    • Infectious agents
    • Contact allergens
  • Psychological stress may exacerbate AD.

Signs and Symptoms

Acute dermatitis

  • Associated with:
    • Severe pruritus
    • Redness
    • Vesicles
    • Exudation
    • May have subacute pattern of pruritus, redness, and scaling

Chronic lesions

  • Marked by:
    • Excoriations
    • Lichenification (thickened skin and deeper or exaggerated skin lines)
    • Postinflammatory hypopigmentation or hyperpigmentation

Infantile AD

  • Eruption of erythematous papules on facial cheeks and extensor surfaces of arms and legs
  • Dry hair, scaly scalp (often)

Childhood AD

  • Begins at approximately 3 years and lasts through puberty
  • The areas most affected include:
    • Antecubital and popliteal folds
    • Neck
    • Flexor surfaces of wrists and ankles
    • More subacute and chronic dermatitis.

Adult AD

  • Additional clinical signs include:
    • Diffuse involvement of the body
    • Xerosis
    • Lichenification
    • Central facial pallor

Other clinical manifestations

  • Keratosis pilaris
    • Characteristic goose flesh appearance secondary to multiple, small, skin-colored or mildly erythematous keratotic papules located on upper arms, thighs, and facial cheeks
  • Lichen spinulosus
    • Tiny hairlike spines top the small papules that occur in crops on various locations
  • Pityriasis alba
  • Dennie-Morgan folds
  • Urticaria
  • Hyperlinear palms
  • Juvenile plantar dermatosis
    • Mainly affects the feet, rarely the hands
    • Produces shiny, fissured skin on the plantar surfaces
  • Nummular eczema
  • Cataracts

Differential Diagnosis

  • Seborrhea is associated with scaling, commonly on the scalp, forehead, and around the eyebrows.
  • Can be accompanied by pruritus
  • Contact dermatitis (allergic and irritant forms)
    • Diagnosis often requires positive exposure history to the potential offending agent.
    • Limited in distribution on the body to the area of contact
    • More likely to have acute onset and localized appearance
  • Psoriasis
  • Scabies
  • Dermatophyte infection
  • Systemic immunologic or metabolic disorders
    • Wiskott-Aldrich syndrome
    • Leiner disease
    • Histiocytosis X
    • Ataxia telangiectasia
    • Ahistidinemia
    • Agammaglobulinemia
    • Hartnup disease
    • Hurler syndrome
    • Eosinophilic gastroenteritis
    • Acrodermatitis enteropathica
    • Phenylketonuria

Diagnostic Approach

  • Diagnosis is determined solely by history and clinical examination.
  • Criteria for diagnosis (patient characteristics to look for)
    • Major criteria (all must be present)
      • Pruritus
      • Typical morphology and distribution
        • Facial and extensor involvement during infancy and early childhood
        • Flexural lichenification and linearity by adolescence
      • Chronic or recurring dermatitis
    • Minor criteria (≥ 2 must be present)
      • Personal or family history of atopy (eg, asthma, allergic rhinoconjunctivitis, atopic dermatitis)
      • Immediate skin test reactivity
      • White dermatographism or delayed blanch to cholinergic agents
      • Anterior subcapsular cataracts
    • Associated conditions (≥ 4 must be present)
      • Xerosis, ichthyosis, hyperlinear palms
      • Pityriasis alba
      • Keratosis pilaris
      • Facial pallor, infraorbital darkening (allergic shiner)
      • Dennie-Morgan fold
      • Elevated serum IgE level
      • Keratoconus
      • Nonspecific hand dermatitis
      • Recurring cutaneous infections
  • Patients may have AD and not meet these criteria.

Laboratory Findings

  • No routine laboratory studies are needed for diagnosis.
  • Specific tests to rule out other disorders, on a case-by-case basis
    • If infections are recurrent, consider an immunodeficiency work up.
  • Bacterial cultures of encrusted or exudative skin lesions/nares to detect staphylococcal organisms are warranted when:
    • Secondary infection is suspected
    • Improvement is not noted with standard therapy
  • Patch testing may be considered to pinpoint potential antigenic triggers, which may add a component of contact dermatitis.
  • Skin biopsy may be necessary when the definitive diagnosis is in question.

Treatment Approach

  • Treatment of uncomplicated cases
    • Treatment to relieve dryness, inflammation, and pruritus and eradicate secondary bacterial infections
    • Daily applications of emollients (cream or ointment), especially after brief warm baths
      • Ointments are better than emollients in more severe cases.
      • If discomfort (stinging sensation) occurs or if ointment feels too occlusive (eg, in humid weather), creams can be substituted.
    • Bathing should last no longer than 5 minutes.
      • Mild soaps or nondetergent cleansers are recommended.
      • Pat dry with a towel and apply emollient immediately to all skin.
      • Apply prescription topical medicines to affected areas.
    • Inflammation is best treated with corticosteroids.
      • Generally, ointments tend to work better than creams.
        • Ointments remain the choice for chronic dermatitis in which dryness and lichenification predominate.
      • Creams
        • Sometimes preferred for cosmetic appeal
        • Can be used for acute weeping, erythematous lesions
  • Treatment of complicated cases
    • If flares continue despite compliance with medication and appropriate skin care, a secondary infection may be responsible that requires treatment.
    • Many patients have significant colonization with Staphylococcus aureus.
      • If S aureus superinfection occurs, hospitalization for aggressive care and intravenous antibiotics may be required.
      • Skin cultures may help identify appropriate antibiotic sensitivities.
      • Application of nasal mupirocin may be necessary to eradicate bacterial carriage.
    • May also require treatment for herpes simplex virus, human papillomavirus (HPV), and molluscum contagiosum

Specific Treatments

Steroids

  • Low-potency topical agents, such as 1% hydrocortisone or desonide:
    • Can be used for mild disease, even on the diaper area and face
    • Twice-daily dosing should be limited to a 2-week course or less.
  • Mid- to high-potency steroids, such as triamcinolone or fluocinonide:
    • Can be used in more severe cases on the trunk and extremities
  • Strong, halogenated steroids:
    • Should not be applied to the face, axillae, or groin
    • Oral systemic steroid taper should rarely be prescribed.
  • Most worrisome side effects
    • Dermal and epidermal atrophy
    • Suppression of the pituitary-adrenal axis
    • Applying topical steroids to the occluded groin area of a diapered child increases the risk of systemic side effects.

Nonsteroidal immunomodulators and other topical medications

  • Topical tacrolimus and pimecrolimus
    • Approved for children ≥ 2 years of age
    • Most efficacious in mild to moderate disease
    • Alternatives to topical steroids
    • Can be applied to the face
    • Theoretical risk of cancer
  • Other topical medications, coal tar and doxepin, are not routinely prescribed by pediatricians.

Pharmacologic therapy

  • Antihistamines may help relieve pruritus, especially if dermatitis accompanies allergic rhinitis, urticaria, and sleep disturbance.
  • Efficacy of alternative medicine, such as herbal or probiotic supplementation, remains unknown.

Behavior modification

  • Teach the child to rub rather than scratch.
  • Have the child wear mittens or socks on his or her hands when in bed at night to reduce the itch-scratch cycle.
  • Trim the fingernails frequently to avoid trauma and infection.

Diet

  • Dietary management is controversial, and changes should be made judiciously.
  • Peanuts, milk, and eggs are the most common food culprits.
  • If food allergies are highly likely, as determined by a pediatric allergist, then strict avoidance of foods that serve as antigenic triggers should be encouraged; the most common are:
    • Cow milk
    • Hen eggs
    • Soy
    • Peanuts
    • Tree nuts (and seeds)
    • Wheat
    • Fish and shellfish

Secondary infections

  • Vesicants
  • Immunomodulators
  • Cryotherapy
  • Ablation with carbon dioxide laser
  • Molluscum contagiosum treatments
    • Manual expression
    • Cryotherapy
    • Topical application of cantharidin or imiquimod
  • Widespread herpes infection requires treatment with intravenous acyclovir.

Aggressive interventions for severe cases

  • Prescribed at the discretion of the skin experts
    • Systemic immunomodulators
    • Ultraviolet light therapy

When to Admit

  • Severe cases requiring systemic immunomodulation
  • Extensive secondary bacterial infection requiring intravenous antibiotics
  • Widespread herpes infection (eczema herpeticum, Kaposi varicelliform eruption)

When to Refer

  • Recalcitrant cases should be referred to a dermatologist or allergist.
  • Secondary HPV or molluscum contagiosum infections should be referred to a dermatologist for aggressive treatment.

Complications

  • S aureus superinfection
    • Hospitalization for aggressive care and intravenous antibiotics may be required.
    • Skin cultures may help identify antibiotic sensitivities.
    • Application of nasal mupirocin may be necessary to eradicate bacterial carriage.
  • Herpes infection, known as eczema herpeticum or Kaposi varicelliform eruption:
    • Requires treatment with intravenous acyclovir.
  • HPV infection
  • Molluscum contagiosum infection

Prevention

  • AD cannot be prevented, but meticulous adherence to proper skin care can control symptoms and secondary infection.
  • Moisturization of the skin with daily applications of emollients, especially after bathing, is crucial to keep the skin hydrated.
  • Prophylactic avoidance of food allergens, both for lactating mothers and infants via exclusive breastfeeding in the first 6 months of life, may be helpful in families with a strong family history of atopy.

Medical Decision Support

AAP Policy Statements

Suggested Resources

Atopic Dermatitis is a sample topic found in Point-of-Care Quick Reference

To find other Point-of-Care Quick Reference topics, please login.

Content Manager
Display all Sections
Get Permissions
Font Size
Print PagePrint Topic
CrossLinks
Acyclovir
Acyclovir
Cephalexin
Chapter 240: Atopic Dermatitis
Coal Tar
Doxepin
Fluocinonide
HydrOXYzine
Loratadine
Mupirocin
Pimecrolimus
Tacrolimus
Triamcinolone
Related Content
Chapter 240: Atopic Dermatitis

search ...